Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial

dc.authoridCan, Gulbeyaz/0000-0002-5368-0893
dc.authorwosidCan, Gulbeyaz/Q-2079-2015
dc.contributor.authorKurt, Seda
dc.contributor.authorCan, Gulbeyaz
dc.date.accessioned2024-06-12T11:12:18Z
dc.date.available2024-06-12T11:12:18Z
dc.date.issued2018
dc.departmentTrakya Üniversitesien_US
dc.description.abstractPurpose: The current experimental study aimed to evaluate the effectiveness of reflexology on the management of symptoms and functions of chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients. Method: This study was conducted as a randomized controlled trial in 60 patients (30 experimental and 30 control patients) who had chemotherapy-induced Grade II-IV peripheral neuropathy complaints from July 2013 to November 2015. Data were collected using the patient identification form, European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy (EORTC-CIPN-20) form, and BPI (used for related chemotherapy-induced peripheral neuropathy symptoms). Results: The majority of the patients were being treated for gastrointestinal or breast cancer and were primarily receiving Eloxatine- or taxane-based treatment. It was found that reflexology applications did not lead to differences in either group in terms of peripheral neuropathy severity and incidence (p > 0.05) and only led to improvement in sensory functions in the experimental group (p < 0.05). Conclusions: It was determined that reflexology is not an effective method in the management of patients' activity levels, walking ability etc. and motor, autonomic functions related CIPN, but reflexology is effective method in the management of patients' sensory functions related CIPN. Key Words: Peripheral neuropathy, reflexology, chemotherapy, EORTC QLQ-CIPN-20, BPI.en_US
dc.identifier.doi10.1016/j.ejon.2017.11.001
dc.identifier.endpage19en_US
dc.identifier.issn1462-3889
dc.identifier.issn1532-2122
dc.identifier.pmid29353627en_US
dc.identifier.scopus2-s2.0-85034098224en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage12en_US
dc.identifier.urihttps://doi.org/10.1016/j.ejon.2017.11.001
dc.identifier.urihttps://hdl.handle.net/20.500.14551/23106
dc.identifier.volume32en_US
dc.identifier.wosWOS:000424174800002en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofEuropean Journal Of Oncology Nursingen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPeripheral Neuropathyen_US
dc.subjectReflexologyen_US
dc.subjectChemotherapyen_US
dc.subjectEORTC QLQCIPN-20en_US
dc.subjectBPIen_US
dc.subjectAcupunctureen_US
dc.titleReflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trialen_US
dc.typeArticleen_US

Dosyalar